The Manufacturers Life Insurance Company Trims Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

The Manufacturers Life Insurance Company lowered its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 291,112 shares of the medical instruments supplier’s stock after selling 7,325 shares during the quarter. The Manufacturers Life Insurance Company owned 0.15% of DENTSPLY SIRONA worth $7,877,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XRAY. Comerica Bank raised its position in DENTSPLY SIRONA by 2.9% in the first quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock valued at $1,413,000 after purchasing an additional 1,205 shares during the period. Cetera Advisors LLC raised its position in DENTSPLY SIRONA by 18.6% in the first quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock valued at $566,000 after purchasing an additional 2,675 shares during the period. Teachers Retirement System of The State of Kentucky raised its position in DENTSPLY SIRONA by 6.2% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 19,370 shares of the medical instruments supplier’s stock valued at $642,000 after purchasing an additional 1,130 shares during the period. OLD National Bancorp IN raised its position in DENTSPLY SIRONA by 84.2% in the second quarter. OLD National Bancorp IN now owns 13,560 shares of the medical instruments supplier’s stock valued at $338,000 after purchasing an additional 6,198 shares during the period. Finally, Sound Income Strategies LLC raised its holdings in shares of DENTSPLY SIRONA by 14,799.9% in the 2nd quarter. Sound Income Strategies LLC now owns 118,305 shares of the medical instruments supplier’s stock valued at $2,947,000 after buying an additional 117,511 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

XRAY has been the topic of several research analyst reports. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research cut their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Evercore ISI cut their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. UBS Group cut their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday. Finally, Robert W. Baird cut their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $28.40.

DENTSPLY SIRONA Trading Up 0.4 %

NASDAQ:XRAY opened at $19.46 on Thursday. The stock has a 50-day simple moving average of $22.17 and a 200-day simple moving average of $24.59. The stock has a market cap of $3.87 billion, a P/E ratio of -9.40, a P/E/G ratio of 1.94 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 EPS. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.